ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients.

Saved in:
Bibliographic Details
Title: ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients.
Authors: Voss RK; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Massarweh NN; Center for Innovations in Quality, Effectiveness, and Safety, Michael E. DeBakey VA Medical Center, Houston, TX, USA.; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA., Roland CL; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. clroland@mdanderson.org.
Source: Annals of surgical oncology [Ann Surg Oncol] 2021 Dec; Vol. 28 (13), pp. 9169-9170. Date of Electronic Publication: 2021 May 20.
Publication Type: Journal Article; Comment
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-021-10162-3